skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Gale Academic OneFile remover Nome da Publicação: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma

Hiraoka, Atsushi ; Kumada, Takashi ; Atsukawa, Masanori ; Hirooka, Masashi ; Tsuji, Kunihiko ; Ishikawa, Toru ; Takaguchi, Koichi ; Kariyama, Kazuya ; Itobayashi, Ei ; Tajiri, Kazuto ; Shimada, Noritomo ; Shibata, Hiroshi ; Ochi, Hironori ; Tada, Toshifumi ; Toyoda, Hidenori ; Nouso, Kazuhiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Hayama, Korenobu ; Imai, Michitaka ; Joko, Kouji ; Tanaka, Hironori ; Tamai, Tsutomu ; Koizumi, Yohei ; Hiasa, Yoichi ; Michitaka, Kojiro ; Kudo, Masatoshi

Oncology, 2019-11, Vol.97 (5), p.277-285 [Periódico revisado por pares]

Basel, Switzerland: S. Karger AG

Texto completo disponível

Citações Citado por
2
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma

Hiraoka, Atsushi ; Kumada, Takashi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Kakizaki, Satoru ; Shimada, Noritomo ; Kawata, Kazuhito ; Naganuma, Atsushi ; Kosaka, Hisashi ; Ohama, Hideko ; Tada, Fujimasa ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Iijima, Hiroko ; Kaibori, Masaki ; Hiasa, Yoichi ; Kudo, Masatoshi

Oncology, 2022-12, Vol.100 (12), p.645-654 [Periódico revisado por pares]

Basel, Switzerland: S. Karger AG

Texto completo disponível

Citações Citado por
3
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings

Ohama, Hideko ; Hiraoka, Atsushi ; Tada, Toshifumi ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Kakizaki, Satoru ; Shimada, Noritomo ; Kawata, Kazuhito ; Naganuma, Atsushi ; Kosaka, Hisashi ; Matono, Tomomitsu ; Shibata, Hiroshi ; Aoki, Tomoko ; Tada, Fujimasa ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Koizumi, Yohei ; Nakamura, Shinichiro ; Iijima, Hiroko ; Kaibori, Masaki ; Hiasa, Yoichi ; Kudo, Masatoshi ; Kumada, Takashi

Oncology, 2023-09, Vol.101 (9), p.542-552 [Periódico revisado por pares]

Basel, Switzerland

Texto completo disponível

Citações Citado por
4
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Persano, Mara ; Rimini, Margherita ; Tada, Toshifumi ; Suda, Goki ; Shimose, Shigeo ; Kudo, Masatoshi ; Cheon, Jaekyung ; Finkelmeier, Fabian ; Lim, Ho Yeong ; Presa, José ; Masi, Gianluca ; Yoo, Changhoon ; Lonardi, Sara ; Stefanini, Bernardo ; Kumada, Takashi ; Sakamoto, Naoya ; Iwamoto, Hideki ; Aoki, Tomoko ; Chon, Hong Jae ; Himmelsbach, Vera ; Montes, Margarida ; Vivaldi, Caterina ; Soldà, Caterina ; Hiraoka, Atsushi ; Sho, Takuya ; Niizeki, Takashi ; Nishida, Naoshi ; Steup, Christoph ; Hirooka, Masashi ; Kariyama, Kazuya ; Tani, Joji ; Atsukawa, Masanori ; Takaguchi, Koichi ; Itobayashi, Ei ; Fukunishi, Shinya ; Tsuji, Kunihiko ; Ishikawa, Toru ; Tajiri, Kazuto ; Ochi, Hironori ; Yasuda, Satoshi ; Toyoda, Hidenori ; Ogawa, Chikara ; Nishimura, Takashi ; Hatanaka, Takeshi ; Kakizaki, Satoru ; Shimada, Noritomo ; Kawata, Kazuhito ; Tada, Fujimasa ; Ohama, Hideko ; Nouso, Kazuhiro ; Morishita, Asahiro ; Tsutsui, Akemi ; Nagano, Takuya ; Itokawa, Norio ; Okubo, Tomomi ; Arai, Taeang ; Imai, Michitaka ; Kosaka, Hisashi ; Naganuma, Atsushi ; Koizumi, Yohei ; Nakamura, Shinichiro ; Kaibori, Masaki ; Iijima, Hiroko ; Hiasa, Yoichi ; Burgio, Valentina ; Della Corte, Angelo ; Ratti, Francesca ; De Cobelli, Francesco ; Aldrighetti, Luca ; Scartozzi, Mario ; Cascinu, Stefano ; Casadei-Gardini, Andrea

Oncology, 2023-05, Vol.101 (5), p.283-291 [Periódico revisado por pares]

Basel, Switzerland: S. Karger AG

Texto completo disponível

Citações Citado por
5
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study

Ogawa, Chikara ; Morita, Masahiro ; Omura, Akina ; Noda, Teruyo ; Kubo, Atsushi ; Matsunaka, Toshihiro ; Tamaki, Hiroyuki ; Shibatoge, Mitsushige ; Tsutsui, Akemi ; Senoh, Tomonori ; Nagano, Takuya ; Takaguchi, Kouichi ; Tani, Joji ; Morishita, Asahiro ; Yoneyama, Hirohito ; Masaki, Tsutomu ; Moriya, Akio ; Ando, Masaharu ; Deguchi, Akihiro ; Kokudo, Yasutaka ; Minami, Yasunori ; Ueshima, Kazuomi ; Sakurai, Toshiharu ; Nishida, Naoshi ; Kudo, Masatoshi

Oncology, 2017-01, Vol.93 (1), p.113-119 [Periódico revisado por pares]

Basel, Switzerland

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.